Research programme: cancer gene therapy - Fuso/GenVec
Latest Information Update: 29 Jun 2017
At a glance
- Originator Fuso Pharmaceutical Industries; GenVec
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer